Disease | lung cancer |
Phenotype | C0206695|neuroendocrine carcinoma |
Sentences | 1 |
PubMedID- 25953679 | Methods: we investigated 64 patients (median age: 68 years; men: 22; women: 42; adenocarcinoma: 61; adenosquamous cell carcinoma: 2; combined large cell neuroendocrine carcinoma: 1) with recurrent lung cancer after complete resection who received gefitinib for the recurrent lesions and in whom the tumors had egfr gene mutations. |
Page: 1